May 12, 2017 / 1:14 PM / 2 months ago

BRIEF-Aptevo Therapeutics reports Q1 loss per share $0.48

1 Min Read

May 12 (Reuters) - Aptevo Therapeutics Inc

* Aptevo Therapeutics reports first quarter 2017 financial results

* Q1 loss per share $0.48

* Aptevo Therapeutics Inc - total product sales revenue was $7.4 million for first three months ended march 31, 2017, compared to $7.9 million

* Aptevo Therapeutics Inc - Aptevo and midcap financial trust agreed to amend a credit agreement initially executed in august 2016

* Aptevo Therapeutics Inc - amendment extends time period through which company can draw second tranche from august 2017 to march 2018

* Aptevo Therapeutics - amendment modifies minimum net commercial product revenue requirements which co is required to achieve on a rolling twelve-month basis

* Aptevo Therapeutics Inc - amendment increases exit fee from 5.75 percent for repayment or prepayment to 6.75 percent Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below